Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402.
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2009 |
| Author/s |
author: Everett E Vokes |
| Publication date | August 24, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |